Literature DB >> 12871334

FGF-2 but not FGF-1 binds fibrin and supports prolonged endothelial cell growth.

A Sahni1, O D Altland, C W Francis.   

Abstract

Endothelial cell viability and growth are dependent on both polypeptide growth factors, and integrin-mediated matrix interactions. We have now examined the ability of fibrin-binding and non-binding growth factors to support long-term endothelial cell growth in the presence or absence of the soluble form. Endothelial cells were cultured on a fibrin surface, with or without FGF-1 or FGF-2, and proliferation was determined by (3)H-thymidine incorporation. Cells cultured on fibrin with no growth factor showed minimal proliferation up to 96 h. In contrast, when FGF-2 was incorporated into fibrin, proliferation was increased 6.5 +/- 0.6-fold, equal to growth on a fibrin surface with FGF-2 continually present in the medium. Thymidine incorporation was similar when cells were cultured on a fibrin surface that had been incubated with FGF-2 and then the growth factor removed (8.6 +/- 0.5-fold). In contrast to results with FGF-2, a surface of fibrin exposed to FGF-1 supported minimal growth, whereas growth was comparable to either FGF-1 or FGF-2 present in the medium. Comparable results were observed when proliferation was quantitated by cell counting at times up to 48 h. Binding studies demonstrated no high-affinity interaction of FGF-1 with fibrinogen or fibrin. We conclude that FGF-2 bound to fibrin supports prolonged endothelial cell growth as well as soluble FGF-2, whereas FGF-1 does not bind to fibrin and can support endothelial cell growth only if continually present in soluble form. Fibrin may serve as a matrix reservoir for FGF-2 to support cell growth at sites of injury or thrombosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871334     DOI: 10.1046/j.1538-7836.2003.00250.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  13 in total

1.  Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage.

Authors:  Christian Schachtrup; Jae K Ryu; Matthew J Helmrick; Eirini Vagena; Dennis K Galanakis; Jay L Degen; Richard U Margolis; Katerina Akassoglou
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

2.  Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling.

Authors:  Seiji Mori; Chun-Yi Wu; Satoshi Yamaji; Jun Saegusa; Biao Shi; Zi Ma; Yasuko Kuwabara; Kit S Lam; R Rivkah Isseroff; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

3.  Inkjet-based biopatterning of bone morphogenetic protein-2 to spatially control calvarial bone formation.

Authors:  Gregory M Cooper; Eric D Miller; Gary E Decesare; Arvydas Usas; Emily L Lensie; Michael R Bykowski; Johnny Huard; Lee E Weiss; Joseph E Losee; Phil G Campbell
Journal:  Tissue Eng Part A       Date:  2010-05       Impact factor: 3.845

Review 4.  Inspired by Nature: Hydrogels as Versatile Tools for Vascular Engineering.

Authors:  Ulrich Blache; Martin Ehrbar
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-07-01       Impact factor: 4.730

5.  FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis.

Authors:  Abha Sahni; Alok A Khorana; Raymond B Baggs; Hu Peng; Charles W Francis
Journal:  Blood       Date:  2005-09-13       Impact factor: 22.113

6.  Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice.

Authors:  Jessica I Mollmark; Andrew J-H Park; Justin Kim; Thomas Z Wang; Sarah Katzenell; Samantha L Shipman; Lyubomir G Zagorchev; Michael Simons; Mary Jo Mulligan-Kehoe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-13       Impact factor: 8.311

7.  Microparticle surface protein are associated with experimental venous thrombosis: a preliminary study.

Authors:  Newaj M Abdullah; Maureen Kachman; Angela Walker; Angela E Hawley; Shriley K Wrobleski; Daniel D Myers; John R Strahler; Philip C Andrews; Goerge C Michailidis; Eduardo Ramacciotti; Peter K Henke; Thomas W Wakefield
Journal:  Clin Appl Thromb Hemost       Date:  2009 Mar-Apr       Impact factor: 2.389

Review 8.  Hydrogel biomaterials and their therapeutic potential for muscle injuries and muscular dystrophies.

Authors:  Rachel Lev; Dror Seliktar
Journal:  J R Soc Interface       Date:  2018-01       Impact factor: 4.118

9.  Roles of IL-6-gp130 Signaling in Vascular Inflammation.

Authors:  Tieying Hou; Brian C Tieu; Sutapa Ray; Adrian Recinos Iii; Ruwen Cui; Ronald G Tilton; Allan R Brasier
Journal:  Curr Cardiol Rev       Date:  2008-08

Review 10.  Engineering growth factors for regenerative medicine applications.

Authors:  Aaron C Mitchell; Priscilla S Briquez; Jeffrey A Hubbell; Jennifer R Cochran
Journal:  Acta Biomater       Date:  2015-11-07       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.